Global Hemostasis Valves Market Size, Trends, and Analysis - Forecasts To 2026 By Type (Hemostasis Valve Y-Connectors, One-Handed Hemostasis Valves, Double Y-Connector Hemostasis Valves, Others Hemostasis Valves), By Application (Angioplasty, Angiography), By End-User (Hospitals, Others), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis
Hemostasis generally refers to a physiological mechanism that helps to avoid and stop bleeding. The medical procedure consists of three stages, known as vascular spasm (vasoconstriction), the formation of platelet plugs, and coagulation. The hemophilia valve involves certain genetic disorders, including hemophilia in which, due to a lack of adequate blood-clotting proteins, blood does not clot appropriately.This valve refers to a system that is used during neuroendovascular procedures to reduce the risk of thromboembolism. These are known to maximize and lower the risk of air embolism and blood loss.
To optimize the use of minimally invasive hemostasis valves in catheter devices, vendors are manufacturing valve assemblies that easily fit into the catheter and delivery system.For potential therapeutic catheter development programs, advances in hemostasis valves may therefore be incorporated to give rise to new design possibilities and shorten the development period.Similarly, minimally intrusive hemostasis valve technologies promote enhanced procedural workflow and improved tactile feel and control. This technology guarantees the prolonged longevity of the hemostasis valves and, even after several or large catheter insertions, maintains hemostasis.
Over the projected years, the increasing number of surgical interventions globally, the rising patient pool suffering from different diseases, and the technical advancements in hemostasis valves by producers, are anticipated to push the market. The key factors driving the market for hemostasis valves are the growing demand for hemostasis valves from healthcare professionals as they provide performance in the next-generation catheter and delivery systems and the growing number of research and development to provide innovative devices with new models that respond to customer needs and are easily adjustable.
The development of the product, such as the advancement of features like single-handed and single-user procedures for hemostasis valves and minimally invasive techniques in hemostasis valves, assures long-lasting reliability of hemostasis valves and maintains hemostasis even after multiple or large catheter insertions, affects the market for hemostasis valves.
Heart disease is the largest cause of death globally, as per the WHO statistics, and accounted for approximately 19 million deaths in 2018.The rise of the aging populations worldwide has contributed to the growing prevalence of cardiovascular diseases is a major effect on the growth of the hemostasis valves market.
Thedouble Y-connector hemostasis valves are anticipated to widen at a significant CAGR in 2020 due to the reduced adverse effects of the treatment and a high degree of accuracy is attributed to it.
In 2020, the hemostasis valve Y-connectors segment will lead the market due to the rising number of interventional treatments across the globe is one of the significant factors leading to the growth of the market.The Y connector provides an ergonomic framework to the valve for open handling. The lodging is manufactured using a shaded polycarbonate material that, restricts staining during the sterilization process.
Over the forthcoming years, the angiographyapplication segment is expected to grow at a substantial CAGR.This is attributable to the growing number of treatments for coronary angiography around the world.Moreover, increasing acceptance of angiography devices, and the increasing occurrence of cardiovascular diseases are some of the factors driving the market growth.
It is expected that the hospitals segment will account for the largest market share position in 2020. This is due to rising R&D activities combined with increasing drug development costs. This is mainly due to the increasing number of hospitals in emerging countries due to initiatives for infrastructural growth and the growing number of patients who prefer surgical procedures in hospitals.As healthcare reform comes into effect effortlessly, hospitals are likely to see a huge surge of new patients and governments are introducing new policies to optimize patient flows. To increase the demand for hospitals, infrastructures such as healthy food, support services, a positive atmosphere, and patient safety will play a prominent role.
In terms of sales, the North American area remains a significant market shareholder in the projected timeframe.Itis driven by factors that have led to the market due to the increasing occurrence of chronic illness, the increasing number of skilled professionals, and the growing R&D facilities. It is estimated that coronary incidents will occur in about 1,055,000 Americans in the United States in 2019, along with 3,35,000 reoccurrences and 720,000 new coronary injuries that are projected to further increase the demand in the market for hemostasis devices in the coming years due to the growing number of cardiac surgeries.
Additionally, a substantial CAGR rate over the projected timeframe will be exhibited in the Asia-Pacific region.Growing interest and expenditure by leading players in the sector and ongoing joint projects are also accountable for regional investment.The growth can be attributed to the elevated prevalence of cancer coupled with strategic policies and investment in the healthcare sector. Moreover, the growing medical tourism,the rising number of hospitals, the rising demand for quality healthcare,the increasing expenditure on R&D activities along thegrowing urbanization, are some of the factors affecting the growth of the regional sector.
Boston Scientific, Merit Medical Systems, B. Braun, Melsungen AG, Terumo, Scitech, Freudenberg Medical (A Subsidiary of Freudenberg Group), Teleflex Incorporated, Deroyal Industries, Inc., and Abbott,among others are the prime competitors that compete in the market
Please note: This is not an exhaustive list of companies profiled in the report..
In November 2020, Freudenberg Medical recently built its worldwide headquarters in Massachusetts and its new medical production facility in Beverly, Massachusetts.
In April 2018, five manufacturing facilities and other administration building were established in Penang by B.Braun.
We value your investment and offer free customization with every report to fulfil your exact research needs.
The Global Hemostasis Valves Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Hemostasis Valves Market
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?